# High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients

> **NCT00313547** · PHASE4 · TERMINATED · sponsor: **Montreal Heart Institute** · enrollment: 40 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Quinapril 40 mg
- **DRUG:** Quinapril 10 mg and amlodipine 5 mg

## Key facts

- **NCT ID:** NCT00313547
- **Lead sponsor:** Montreal Heart Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-04
- **Primary completion:** 2007-04
- **Final completion:** 2008-03
- **Target enrollment:** 40 (ESTIMATED)
- **Why stopped:** Very difficult to recruit patients/slow recruitment(2 patients in nearly 2 years).
- **Last updated:** 2008-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00313547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00313547, "High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00313547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*